Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. MorphoSys AG
  6. News
  7. Summary
    MOR   DE0006632003

MORPHOSYS AG

(MOR)
  Report
Delayed Xetra  -  11:35 2022-12-09 am EST
15.85 EUR   -2.58%
11:05aEuropean Equities Rise Modestly Friday, But End Week Lower
MT
12/07Global markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
12/07MorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Lower in Wednesday Trading

07/06/2022 | 11:08am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -6.25% 1.65 Delayed Quote.-53.07%
AKARI THERAPEUTICS, PLC -0.74% 0.526 Delayed Quote.-64.67%
BICYCLE THERAPEUTICS PLC -2.86% 30.61 Delayed Quote.-48.23%
BP PLC -0.43% 461.95 Delayed Quote.39.77%
BRENT OIL 0.24% 76.63 Delayed Quote.-1.85%
CARNIVAL CORPORATION -1.77% 8.87 Delayed Quote.-55.12%
EQUINOR ASA -1.96% 358.2 Real-time Quote.54.87%
ERYTECH PHARMA S.A. -9.15% 0.516 Real-time Quote.-75.66%
GRIFOLS, S.A. 2.12% 10.19 Delayed Quote.-39.61%
LOGITECH INTERNATIONAL S.A. 1.50% 56.66 Delayed Quote.-27.39%
MATERIALISE NV -3.09% 9.41 Delayed Quote.-59.32%
MORPHOSYS AG -2.58% 15.85 Delayed Quote.-52.47%
NUCANA PLC -0.03% 0.7998 Delayed Quote.-66.40%
TOTALENERGIES SE -0.92% 56.29 Real-time Quote.26.13%
TRINITY BIOTECH PLC -3.29% 1.2379 Delayed Quote.-13.43%
VEON LTD. -10.42% 0.5221 Delayed Quote.-69.47%
VERONA PHARMA PLC 0.24% 12.46 Delayed Quote.85.42%
WTI -0.79% 71.473 Delayed Quote.-3.72%
All news about MORPHOSYS AG
11:05aEuropean Equities Rise Modestly Friday, But End Week Lower
MT
12/07Global markets live: Glencore, Apple, Netflix, Tesla, Amazon...
MS
12/07MorphoSys Out Licenses Pre-Clinical Oncology Program
AQ
12/06Novartis Signs Licensing Deal for MorphoSys Unit's Cancer Program
MT
12/06MorphoSys Out Licenses Pre-Clinical Oncology Program
EQ
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
12/02Afr : MorphoSys AG: Preliminary announcement of the publication of quarterly reports and q..
EQ
11/28Morphosys Ag : Financial Calendar 2023
EQ
11/28Morphosys : Notification of managers`transactions according to article 19 MAR - Form 6-K
PU
11/28Dd : MorphoSys AG: Krisja Vermeylen, buy
EQ
More news
Analyst Recommendations on MORPHOSYS AG
More recommendations
Financials
Sales 2022 233 M 246 M 246 M
Net income 2022 -481 M -507 M -507 M
Net Debt 2022 - - -
P/E ratio 2022 -1,20x
Yield 2022 -
Capitalization 541 M 570 M 570 M
Capi. / Sales 2022 2,32x
EV / Sales 2023 1,78x
Nbr of Employees 627
Free-Float 98,1%
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MORPHOSYS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Last Close Price 15,85 €
Average target price 27,70 €
Spread / Average Target 74,8%
EPS Revisions
Managers and Directors
Jean-Paul Kress CEO & Chairman-Management Board
Sung H. Lee Chief Financial Officer
Marc Cluzel Chairman-Supervisory Board
Tim Demuth Chief Research & Development Officer
Krisja Vermeylen Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
MORPHOSYS AG-52.47%586
MODERNA, INC.-27.28%70 958
IQVIA HOLDINGS INC.-25.42%39 082
LONZA GROUP AG-39.99%36 246
ALNYLAM PHARMACEUTICALS, INC.40.35%29 282
SEAGEN INC.-19.79%23 253